← Banking With Billy News

+209% upside: $AKTX $8.24 to $25.50. Oncology ADC pivot; reverse split cleared a Nasdaq overhang. 3-analyst mean. Target, not a promise. #Biotech #ClinicalTrial

BWB News TV • 2026-11-10 00:02 UTC • By Billy Odell Tucker-Robinson
+209% upside: $AKTX $8.24 to $25.50. Oncology ADC pivot; reverse split cleared a Nasdaq overhang. 3-analyst mean. Target, not a promise. #Biotech #ClinicalTrial
+209% upside: $AKTX $8.24 to $25.50. Oncology ADC pivot; reverse split cleared a Nasdaq overhang. 3-analyst mean. Target, not a promise. #Biotech #ClinicalTrial
Share this article
𝕏 X / Twitter Facebook LinkedIn WhatsApp
📚 More from Billy’s World
📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly